Chronic hepatitis C: future treatment

QR Code

Chronic hepatitis C: future treatment

Astrid Wendt, Xavier Adhoute, Paul Castellani, Valerie Oules, Christelle Ansaldi, Souad Benali, Marc BourlièreDepartment of Hepato-Gastroenterology, Hôpital Saint-Joseph, Marseille, FranceAbstract: The launch of first-generation protease inhibitors (PIs) is a major step forward...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Wendt A, Adhoute X, Castellani P, Oules V, Ansaldi C, Benali S, Bourlière M
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2014
Sujets:	Therapeutics. Pharmacology RM1-950
Accès en ligne:	https://doaj.org/article/6b217c61852545d88fefd58686a4d89a
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review
par: Aguirre Valadez J, et autres
Publié: (2015)

Pazopanib for the treatment of soft-tissue sarcoma
par: Heudel P, et autres
Publié: (2012)

Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy
par: Xavier Woot de Trixhe, et autres
Publié: (2021)

Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
par: Gillian W Reierson, et autres
Publié: (2009)

Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization
par: Kose E, et autres
Publié: (2014)

The association between NAFLD and risk of chronic kidney disease: a cross-sectional study
par: Ying Cao, et autres
Publié: (2021)

Hemodialysis does not alter in vitro hepatic CYP3A4 and CYP2D6 metabolic activity in uremic serum
par: Decker BS, et autres
Publié: (2013)

Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy
par: Michael A. Tortorici, et autres
Publié: (2021)

Population pharmacokinetic and exposure–response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemia
par: Ekaterina Gibiansky, et autres
Publié: (2021)

Use of ipilimumab in the treatment of melanoma
par: Acharya UH, et autres
Publié: (2013)

High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure
par: Yabuno K, et autres
Publié: (2013)

Impact of the chronic disease self-management program (CDSMP) on self-perceived frailty condition: the EU-EFFICHRONIC project
par: Sabrina Zora, et autres
Publié: (2021)

New perspectives on the treatment of hidradenitis suppurativa
par: Victoria Amat-Samaranch, et autres
Publié: (2021)

Treatment of Cushing disease: overview and recent findings
par: Tatiana Mancini, et autres
Publié: (2010)

Drug-resistant tuberculosis: emerging treatment options
par: Adhvaryu MR, et autres
Publié: (2011)

A Debate on Vitamin C: Supplementation on the Hotline for Critically Ill Patients with COVID-19
par: Ata Mahmoodpoor, et autres
Publié: (2020)

Heterogeneous treatment effect analysis based on machine‐learning methodology
par: Xiajing Gong, et autres
Publié: (2021)

Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review
par: Brennan JL, et autres
Publié: (2013)

Management of antipsychotic treatment discontinuation and interruptions using model-based simulations
par: Samtani MN, et autres
Publié: (2012)

The Treatment for a Patient with Cancer of Unknown Primary: A Case Report
par: QingTao Ni MD, et autres
Publié: (2021)

Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia
par: Portell CA, et autres
Publié: (2013)

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response
par: Li L, et autres
Publié: (2012)

Ceftolozane–tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case series
par: Xing Tan, et autres
Publié: (2019)

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX&reg; mesalamine
par: Nanda K, et autres
Publié: (2012)

Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer
par: Hiroyuki Sayama, et autres
Publié: (2021)

Hematological Changes Following Low Dose Radiation Therapy and Comparison to Current Standard of Care Cancer Treatments
par: Alexandra Jameus, et autres
Publié: (2021)

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX&reg; mesalamine. [Corrigendum]
par: Nanda K, et autres
Publié: (2013)

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
par: Hashemi SN, et autres
Publié: (2012)

The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
par: Davies M, et autres
Publié: (2016)

Chronic tonsillitis and biofilms: a brief overview of treatment modalities [Corrigendum]
par: Abu Bakar M, et autres
Publié: (2018)

RETRACTION NOTICE: A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients
Publié: (2021)

Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’
par: Jin-Tao Guan, et autres
Publié: (2021)

Pharmacometric analyses of alectinib to facilitate approval of the optimal dose for the first‐line treatment of anaplastic lymphoma kinase–positive non‐small cell lung cancer
par: Joy C. Hsu, et autres
Publié: (2021)

Letter to the editor regarding ‘‘Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-analysis: Patiromer and Sodium Zirconium Cyclosilicate in Hyperkalemia’
par: Donna Zarzuela, PharmD, et autres
Publié: (2021)

“Highly Exposed Chinese Herbal Medicine” Combined With Apatinib as Maintenance Treatment Following First-Line or Second-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Single-Arm, Prospective Study
par: Mingqi Wang, et autres
Publié: (2021)

Implications of compromised zinc status on bone loss associated with chronic inflammation in C57BL/6 mice
par: Chongwatpol P, et autres
Publié: (2015)

Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study
par: Wang X, et autres
Publié: (2013)

The effects of grounding (earthing) on inflammation, the immune response, wound healing, and prevention and treatment of chronic inflammatory and autoimmune diseases
par: Oschman JL, et autres
Publié: (2015)

The role of patient preferences in adherence to treatment in chronic disease: a narrative review
par: Serena Losi, et autres
Publié: (2021)

Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study
par: Rambiritch V, et autres
Publié: (2014)